Sign Up to like & get
recommendations!
1
Published in 2017 at "OncoTargets and therapy"
DOI: 10.2147/ott.s133022
Abstract: Glioma is the most common and aggressive human primary tumor in the central nervous system. Despite present clinical advancements, median survival time remains poor in this malignant tumor. Serpin peptidase inhibitor, clade A member 3…
read more here.
Keywords:
glioma patients;
serpin peptidase;
glioma;
prognosis glioma ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1158723
Abstract: Background: Glioma patients often experience unfavorable outcomes and elevated mortality rates. Our study established a prognostic signature utilizing cuproptosis-associated long non-coding RNAs (CRLs) and identified novel prognostic biomarkers and therapeutic targets for glioma. Methods: The…
read more here.
Keywords:
signature;
prognosis glioma;
analysis;
glioma ... See more keywords